nach oben

04.05.2024 | Original Article

Skin assessment in congenital untreated isolated GH deficiency

verfasst von: Cynthia S. Barros-Oliveira, Maria Joseli Melo de Jesus, Viviane C. Campos, Roberto Salvatori, Adriano Antunes de Souza Araújo, Roberto Fernandes Soares Neto, Andrzej Bartke, Vanderlan O. Batista, Augusto Schneider, Keila R. Villar-Gouy, Michal M. Masternak, Ângela C. Leal, Lucas B. Santos, Carla R. P. Oliveira, Elenilde G. Santos, Davi A. Oliveira Simões, Bruno de Santana Silva, Manuel H. Aguiar-Oliveira

Erschienen in: Endocrine

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The separation between the inside and outside through the skin was fundamental for the evolution of prevertebrates, which grow through extrapituitary circuits, to vertebrates, which grow through the somatotrophic axis, namely pituitary growth hormone (GH). and circulating IGF1.Individuals with untreated isolated growth hormone (GH) deficiency (IGHD) due to a mutation in the GH-releasing hormone receptor (GHRH) gene, residing in Itabaianinha, Brazil, are vulnerable to skin cancer and have reduced sweating. However other aspects of their skin physiology are still unknown. Our objectives were to evaluate the number of skin cancers, skin aging, and functional aspects of the skin in this IGHD cohort.

Methods

Twenty-six IGHD individuals and 26 controls matched by age, sex, ethnicity, and occupation were submitted to a biochemical, dermatological and a functional skin assessment by the Multi Probe Adapter Cutometer® MPA 580.

Results

There was no difference in the number of skin cancers and in the degrees of photodamage between the groups. The melanin content in the forearm was similar between the groups but was lower in the buttocks (p = 0.005), as well as skin resistance (p < 0.0001) and elasticity (p = 0.003), lower in the IGHD. There was no difference in hydration and sebum content between the two groups.

Conclusion

IGHD is apparently associated with a neutral profile in terms of skin cancer and photodamage, with similar melanin on the forearm and lower buttocks, lower skin resistance and elasticity, with hydration and sebum similar to controls.

M.H. Aguiar-Oliveira, A. Bartke, Growth hormone deficiency: health and longevity. Endocr Rev 40(2), 575–601 (2019). https://doi.org/10.1210/er.2018-00216CrossRefPubMed

L.A. Oliveira-Neto, J.K.F. Nascimento, R. Salvatori, A.A. Oliveira-Santos, R.S. Girão, E.V. Silva, A.L.M. Santos, M.M. Cunha, M.A.V. Bittencourt, G.T. Rodrigues, B.M.R. Andrade, A.H.A. Oliveira, E.H.O. Valença, M.H. Aguiar-Oliveira, Growth of teeth and bones in adult subjects with congenital untreated isolated growth hormone deficiency. Growth Horm IGF Res 65, 101469 (2022). https://doi.org/10.1016/j.ghir.2022.101469CrossRefPubMed

A.K. Dąbrowska, F. Spano, S. Derler, C. Adlhart, N.D. Spencer, R.M. Rossi, The relationship between skin function, barrier properties, and body-dependent factors. Skin Res Technol 24(2), 165–174 (2018). https://doi.org/10.1111/srt.12424CrossRefPubMed

C.C. Zouboulis, The skin as an endocrine organ. Dermatoendocrinol 1(5), 250–252 (2009). https://doi.org/10.4161/derm.1.5.9499CrossRefPubMedPubMedCentral

C.C. Zouboulis, The human skin as a hormone target and an endocrine gland. Hormones (Athens) 3(1), 9–26 (2004). https://doi.org/10.14310/horm.2002.11109CrossRefPubMed

C. Kanaka-Gantenbein, C. Kogia, M.B. Abdel-Naser, G.P. Chrousos, Skin manifestations of growth hormone-induced diseases. Rev Endocr Metab Disord 17(3), 259–267 (2016). https://doi.org/10.1007/s11154-016-9378-8CrossRefPubMed

A. Tavakkol, J.T. Elder, C.E. Griffiths, K.D. Cooper, H. Talwar, G.J. Fisher, K.M. Keane, S.K. Foltin, J.J. Voorhees, Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin. J Invest Dermatol 99(3), 343–349 (1992). https://doi.org/10.1111/1523-1747CrossRefPubMed

A. Ben-Shlomo, S. Melmed, Skin manifestations in acromegaly. Clin Dermatol 24(4), 256–259 (2006). https://doi.org/10.1016/j.clindermatol.2006.04.011CrossRefPubMed

M. Borlu, Z. Karaca, H. Yildiz, F. Tanriverdi, B. Demirel, G. Elbuken, I. Cakir, H.S. Dokmetas, R. Colak, K. Unluhizarci, F. Kelestimur, Acromegaly is associated with decreased skin transepidermal water loss and temperature, and increased skin pH and sebum secretion partially reversible after treatment. Growth Horm IGF Res 22(2), 82–86 (2012). https://doi.org/10.1016/j.ghir.2012.02.006CrossRefPubMed

10.

F.A. Khamdan, M.A. Shah, M.A. Khamdan, E. Albasri, Acromegaly presenting with resistant acne vulgaris. Case Rep Dermatol 14(2), 151–156 (2022). https://doi.org/10.1159/000525069CrossRefPubMedPubMedCentral

11.

D. Deplewski, R.L. Rosenfield, Role of hormones in pilosebaceous unit development. Endocr Rev 21(4), 363–392 (2000). https://doi.org/10.1210/edrv.21.4.0404CrossRefPubMed

12.

M. Lange, J. Thulesen, U. Feldt-Rasmussen, N.E. Skakkebaek, N. Vahl, J.O. Jørgensen, J.S. Christiansen, S.S. Poulsen, S.B. Sneppen, A. Juul, Skin morphological changes in growth hormone deficiency and acromegaly. Eur J Endocrinol 145(2), 147–153 (2001). https://doi.org/10.1530/eje.0.1450147CrossRefPubMed

13.

F. Tanriverdi, Z. Karaca, K. Unluhizarci, F. Kelestimur, Unusual effects of GH deficiency in adults: a review about the effects of GH on skin, sleep, and coagulation. Endocrine 47(3), 679–689 (2014). https://doi.org/10.1007/s12020-014-0276-0CrossRefPubMed

14.

R. Salvatori, C.Y. Hayashida, M.H. Aguiar-Oliveira, J.A. Phillips, A.H.O. Souza, R.G. Gondo, S.P.A. Toledo, M.M. Conceição, M. Prince, H.G. Maheshwari, G. Baumann, M.A. Levine, Familial Dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. J Clin Endocrinol Metab 84(3), 917–923 (1999). https://doi.org/10.1210/jcem.84.3.5599CrossRefPubMed

15.

M.H. Aguiar-Oliveira, M.S. Gill, A. de, E.S. Barretto, M.R. Alcântara, F. Miraki-Moud, C.A. Menezes, A.H. Souza, C.E. Martinelli, F.A. Pereira, R. Salvatori, M.A. Levine, S.M. Shalet, C. Camacho-Hubner, P.E. Clayton, Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life. J Clin Endocrinol Metab 84(11), 4118–4126 (1999). https://doi.org/10.1210/jcem.84.11.6133CrossRefPubMed

16.

M.H. Aguiar-Oliveira, R. Salvatori, The state of Sergipe contribution to GH research: from Souza Leite to Itabaianinha syndrome. Arch Endocrinol Metab 66(6), 919–928 (2022). https://doi.org/10.20945/2359-3997000000567CrossRefPubMedPubMedCentral

17.

M.H. Aguiar-Oliveira, A.H.O. Souza, C.R.P. Oliveira, V.C. Campos, L.A. Oliveira-Neto, R. Salvatori, MECHANISMS IN ENDOCRINOLOGY: The multiple facets of GHRH/GH/IGF-I axis: lessons from lifetime, untreated, isolated GH deficiency due to a GHRH receptor gene mutation. Eur J Endocrinol 177(2), R85–R97 (2017). https://doi.org/10.1530/EJE-16-1047CrossRefPubMed

18.

M.H. Aguiar-Oliveira, R. Salvatori, Disruption of the GHRH receptor and its impact on children and adults: the Itabaianinha syndrome. Rev Endocr Metab Disord 22(1), 81–89 (2021). https://doi.org/10.1007/s11154-020-09591-4CrossRefPubMed

19.

E. Gomes-Santos, R. Salvatori, T.O. Ferrao, C.R. Oliveira, R.D. Diniz, J.A. Santana et al. Increased visceral adiposity and cortisol to cortisone ratio in adults with congenital lifetime isolated GH deficiency. J Clin Endocrinol Metab 99, 3285–3289 (2014)CrossRefPubMed

20.

M.R. Alcântara, R. Salvatori, P.R. Alcântara, L.M. Nóbrega, V.S. Campos, E.C. Oliveira et al. Thyroid morphology and function in adults with untreated isolated growth hormone deficiency. J Clin Endocrinol Metab 91, 860–864 (2006)CrossRefPubMed

21.

M. Menezes, R. Salvatori, L.D. Melo, I.E. Rocha, C.R. Oliveira, R.M. Pereira et al. Prolactin and sex steroids levels in congenital lifetime isolated GH deficiency. Endocrine 44, 207–211 (2013)CrossRefPubMed

22.

M.H. Aguiar-Oliveira, F.T. Oliveira, R.M. Pereira, C.R. Oliveira, A. Blackford, E.H. Valenca, E.G. Santos, M.B. Gois-Junior, R.A. Meneguz-Moreno, V.P. Araujo, L.A. Oliveira-Neto, R.P. Almeida, M.A. Santos, N.T. Farias, D.C. Silveira, G.W. Cabral, F.R. Calazans, J.D. Seabra, T.F. Lopes, E.O. Rodrigues, L.A. Porto, I.P. Oliveira, E.V. Melo, M. Martari, R. Salvatori, Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene. J Clin Endocrinol Metab 95(2), 714–721 (2010). https://doi.org/10.1210/jc.2009-1879CrossRefPubMed

23.

J.A. Barbosa, R. Salvatori, C.R. Oliveira, R.M. Pereira, C.T. Farias, A.V. Britto, N.T. Farias, A. Blackford, M.H. Aguiar-Oliveira, Quality of life in congenital, untreated, lifetime isolated growth hormone deficiency. Psychoneuroendocrinology 34(6), 894–900 (2009). https://doi.org/10.1016/j.psyneuen.2009.01.001CrossRefPubMed

24.

A.L. Andrade-Guimarães, M.H. Aguiar-Oliveira, R. Salvatori, V.O. Carvalho, F. Alvim-Pereira, C.R.A. Daniel, G.A.M. Brasileiro, A.A. Santana-Ribeiro, H.A. Santos-Carvalho, C.R.P. Oliveira, E.R. Vieira, M.B. Gois-Junior, Adult individuals with congenital, untreated, severe isolated growth hormone deficiency have satisfactory muscular function. Endocrine 63(1), 112–119 (2019). https://doi.org/10.1007/s12020-018-1763-5CrossRefPubMed

25.

C.G. Marinho, L.M. Mermejo, R. Salvatori, J.A.Junior Assirati, C.R.P. Oliveira, E.G. Santos, Â.C.G.B. Leal, C.S. Barros-Oliveira, N.P. Damascena, C.A. Lima, C.T. Farias, A.C. Moreira, M.H. Aguiar-Oliveira, Occurrence of neoplasms in individuals with congenital, severe GH deficiency from the Itabaianinha kindred. Growth Horm IGF Res 41, 71–74 (2018). https://doi.org/10.1016/j.ghir.2018.03.004CrossRefPubMed

26.

C.S. Barros-Oliveira, R. Salvatori, J.S.S. Dos Santos, P.F.C. Santos, A.A. Oliveira-Santos, C.G. Marinho, E.G. Santos, Â.C.G.B. Leal, V.C. Campos, N.P. Damascena, C.R.P. Oliveira, M.H. Aguiar-Oliveira, Sweat and vitamin D status in congenital, lifetime, untreated GH deficiency. Endocrine 65(3), 710–713 (2019). https://doi.org/10.1007/s12020-019-01998-7CrossRefPubMed

27.

M.M. Hamilton, R. Kao, Recognizing and managing complications in laser resurfacing, chemical peels, and dermabrasion. Facial Plast Surg Clin North Am 28(4), 493–501 (2020). https://doi.org/10.1016/j.fsc.2020.06.008CrossRefPubMed

28.

D.E. Holck, J.D. Ng, Facial skin rejuvenation. Curr Opin Ophthalmol 14(5), 246–252 (2003). https://doi.org/10.1097/00055735-200310000-00004CrossRefPubMed

29.

R. Steuerman, O. Shevah, Z. Laron, Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies. Eur J Endocrinol 164(4), 485–489 (2011). https://doi.org/10.1530/EJE-10-0859CrossRefPubMed

30.

Z. Laron, H. Werner, Congenital IGF-1 deficiency protects from cancer: lessons from Laron syndrome. Endocr Relat Cancer 30(9), e220394 (2023). https://doi.org/10.1530/ERC-22-0394CrossRefPubMed

31.

D.A. Lewis, J.B. Travers, A.K. Somani, D.F. Spandau, The IGF-1/IGF-1R signaling axis in the skin: a new role for the dermis in aging-associated skin cancer. Oncogene 29(10), 1475–1485 (2010). https://doi.org/10.1038/onc.2009.440CrossRefPubMed

32.

L. Stătescu, L.M. Trandafir, E. Țarcă, M. Moscalu, M.M. Leon Constantin, L.I. Butnariu, M.F. Trandafirescu, M.C. Tîrnovanu, R. Heredea, A.V. Pătrașcu, D. Botezat, E. Cojocaru, Advancing cancer research: current knowledge on cutaneous neoplasia. Int J Mol Sci 24(13), 11176 (2023). https://doi.org/10.3390/ijms241311176CrossRefPubMedPubMedCentral

33.

M.G. Kemp, D.F. Spandau, J.B. Travers, Impact of age and insulin-like growth factor-1 on DNA damage responses in UV-irradiated human skin. Molecules 22(3), 356 (2017). https://doi.org/10.3390/molecules2203035CrossRefPubMedPubMedCentral

34.

E. Kharazmi, M. Fallah, K. Sundquist, K. Hemminki, Familial risk of early and late onset cancer: nationwide prospective cohort study. BMJ 345, e8076 (2012). https://doi.org/10.1136/bmj.e8076CrossRefPubMedPubMedCentral

35.

A. Slominski, D.J. Tobin, S. Shibahara, J. Wortsman, Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 84(4), 1155–1228 (2004). https://doi.org/10.1152/physrev.00044.2003CrossRefPubMed

36.

T.H. Nasti, L. Timares, MC1R, eumelanin and pheomelanin: their role in determining the susceptibility to skin cancer. Photochem Photobiol 91(1), 188–200 (2015). https://doi.org/10.1111/php.12335CrossRefPubMed

37.

G.E. Costin, V.J. Hearing, Human skin pigmentation: melanocytes modulate skin color in response to stress. FASEB J 21(4), 976–994 (2007). https://doi.org/10.1096/fj.06-6649revCrossRefPubMed

38.

R.M. Halder, K.M. Bang, Skin cancer in blacks in the United States. Dermatol Clin 6(3), 397–405 (1988)CrossRefPubMed

39.

M. Brenner, V.J. Hearing, The protective role of melanin against UV damage in human skin. Photochem Photobiol 84(3), 539–549 (2008). https://doi.org/10.1111/j.1751-1097.2007.00226.xCrossRefPubMedPubMedCentral

40.

A.H. Souza, M.I. Farias, R. Salvatori, G.M. Silva, J.A. Santana, F.A. Pereira, F.J. de Paula, E.H. Valença, E.V. Melo, R.A. Barbosa, R.M. Pereira, M.B. Gois-Junior, M.H. Aguiar-Oliveira, Lifetime, untreated isolated GH deficiency due to a GH-releasing hormone receptor mutation has beneficial consequences on bone status in older individuals and does not influence their abdominal aorta calcification. Endocrine 47(1), 191–197 (2014). https://doi.org/10.1007/s12020-013-0118-5CrossRefPubMed

41.

E.J. Horesh, J. Gherardini, M. Alam, J. Rodriguez-Feliz, A.J. Bauman, J. Chéret, R. Paus, Human hair follicles operate a functional peripheral equivalent of the hypothalamic-pituitary-somatotropic axis ex vivo. J Invest Dermatol 143(5), 868–871 (2023). https://doi.org/10.1016/j.jid.2022.09.660CrossRefPubMed

42.

T.D. Saccon, A. Schneider, C.G. Marinho, A.D.C. Nunes, S. Noureddine, J. Dhahbi, Y.O. Nunez Lopez, G. LeMunyan, R. Salvatori, C.R.P. Oliveira, A.A. Oliveira-Santos, N. Musi, A. Bartke, M.H. Aguiar-Oliveira, M.M. Masternak, Circulating microRNA profile in humans and mice with congenital GH deficiency. Aging Cell 20(7), e13420 (2021). https://doi.org/10.1111/acel.13420CrossRefPubMedPubMedCentral

43.

R. Paus, A. Sevilla, J.M. Grichnik, Human Hair graying revisited: principles, misconceptions, and key research frontiers. J Invest Dermatol (2023). https://doi.org/10.1016/j.jid.2023.09.276

44.

S.M. Ostojic, Eumelanin-driven production of molecular hydrogen: a novel element of skin defense? Med Hypotheses 85(2), 237–238 (2015). https://doi.org/10.1016/j.mehy.2015.04.014CrossRefPubMed

45.

L. Rittié, G.J. Fisher, Natural and sun-induced aging of human skin. Cold Spring Harb Perspect Med 5(1), a015370 (2015). https://doi.org/10.1101/cshperspect.a015370CrossRefPubMedPubMedCentral

46.

W. Yang, V.R. Sherman, B. Gludovatz, E. Schaible, P. Stewart, R.O. Ritchie, M.A. Meyers, On the tear resistance of skin. Nat Commun 6, 6649 (2015). https://doi.org/10.1038/ncomms7649CrossRefPubMed

47.

J.A. Barreto-Filho, M.R. Alcântara, R. Salvatori, M.A. Barreto, A.C. Sousa, V. Bastos, A.H. Souza, R.M. Pereira, P.E. Clayton, M.S. Gill, M.H. Aguiar-Oliveira, Familial isolated growth hormone deficiency is associated with increased systolic blood pressure, central obesity, and dyslipidemia. J Clin Endocrinol Metab 87(5), 2018–2023 (2002). https://doi.org/10.1210/jcem.87.5.8474CrossRefPubMed

48.

P.D. Menezes, L.A. Frank, B.D. Lima, Y.M. de Carvalho, M.R. Serafini, L.J. Quintans-Júnior, A.R. Pohlmann, S.S. Guterres, A.A. Araújo, Hesperetin-loaded lipid-core nanocapsules in polyamide: a new textile formulation for topical drug delivery. Int J Nanomedicine 15(12), 2069–2079 (2017). https://doi.org/10.2147/IJN.S124564CrossRef

49.

P.D.P. Menezes, C.V.C. Gomes, Y.M.B.G. de Carvalho, N.G.L. Santos, V.M. Andrade, A.M.S. Oliveira, C.M. de Lima, A.A.S. Araújo, Evaluation of the Use of compressive stockings impregnated with hesperetin-based nanocapsules in the healing of venous ulcers: a case report. Clin Med Insights Case Rep 18(12), 1179547619858977 (2019). https://doi.org/10.1177/1179547619858977CrossRef

50.

F. Tanriverdi, M. Borlu, H. Atmaca, C.A. Koc, K. Unluhizarci, S. Utas, F. Kelestimur, Investigation of the skin characteristics in patients with severe GH deficiency and the effects of 6 months of GH replacement therapy: a randomized placebo-controlled study. Clin Endocrinol (Oxf) 65(5), 579–585 (2006). https://doi.org/10.1111/j.1365-2265.2006.02631.xCrossRefPubMed

51.

T.X. Cong, D. Hao, X. Wen, X.H. Li, G. He, X. Jiang, From pathogenesis of acne vulgaris to anti-acne agents. Arch Dermatol Res 311(5), 337–349 (2019). https://doi.org/10.1007/s00403-019-01908-xCrossRefPubMed

52.

J.L. Oliveira, M.H. Aguiar-Oliveira, A. D’Oliveira Jr, R.M. Pereira, C.R. Oliveira, C.T. Farias, J.A. Barreto-Filho, F.D. Anjos-Andrade, C. Marques-Santos, A.C. Nascimento-Junior, E.O. Alves, F.T. Oliveira, V.C. Campos, R. Ximenes, A. Blackford, G. Parmigiani, R. Salvatori, Congenital growth hormone (GH) deficiency and atherosclerosis: effects of GH replacement in GH-naive adults. J Clin Endocrinol Metab 92(12), 4664–4670 (2007). https://doi.org/10.1210/jc.2007-1636CrossRefPubMed

53.

H.S. Yoon, J.R. Kim, G.Y. Park, J.E. Kim, D.H. Lee, K.W. Lee, J.H. Chung, Cocoa flavanol supplementation influences skin conditions of photo-aged women: A 24-week double-blind, randomized, controlled trial. J Nutr 146(1), 46–50 (2016). https://doi.org/10.3945/jn.115.217711CrossRefPubMed

Titel: Skin assessment in congenital untreated isolated GH deficiency
verfasst von: Cynthia S. Barros-Oliveira
Maria Joseli Melo de Jesus
Viviane C. Campos
Roberto Salvatori
Adriano Antunes de Souza Araújo
Roberto Fernandes Soares Neto
Andrzej Bartke
Vanderlan O. Batista
Augusto Schneider
Keila R. Villar-Gouy
Michal M. Masternak
Ângela C. Leal
Lucas B. Santos
Carla R. P. Oliveira
Elenilde G. Santos
Davi A. Oliveira Simões
Bruno de Santana Silva
Manuel H. Aguiar-Oliveira
Publikationsdatum: 04.05.2024
Verlag: Springer US
Erschienen in: Endocrine
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-024-03840-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen